Animal models of adenomyosis as a basis for the development of new treatment methods. Part I. Creation of a highly reproducible model of adenomyosis in female Wistar rats

In: Journal of obstetrics and women's diseases · 2025 · vol. 74(1) , pp. 67–73 · doi:10.17816/jowd641737 · W4409695594
article OA: closed CC0 ⤵ 1 in-corpus citation
View on OpenAlex View at publisher
AI-generated summary by claude@2026-06, 2026-06-09

This study established a highly reproducible rat model of adenomyosis by administering tamoxifen from day 2 to day 5 and assessing outcomes on day 30.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

BACKGROUND: The creation of an experimental model of adenomyosis is of scientific and practical interest, which allows for the evaluation of the effectiveness and pathogenetically substantiated therapy of adenomyosis in the future on the created highly reproducible model of the disease. AIM: The aim of this study was to create a highly reproducible model of adenomyosis in neonatal Wistar rats. MATERIALS AND METHODS: This article presents the first stage of the experiment on newborn Wistar rats, including the creation of a highly reproducible model of adenomyosis with different schemes and frequency of tamoxifen administration, as well as different periods of animal withdrawal. To achieve the set goal, 26 newborn female rats were orally administered an estrogen receptor blocker (tamoxifen 20 mg) at a rate of 1 mg of the drug per 1 kg of animal body weight once a day. To determine the most optimal regimen for administering tamoxifen, the animals were divided into four groups. Group 1 (n = 6) received the drug from day 2 to day 5 of postembryonic development. Group 2 (n = 8) received the drug from day 3 to day 8. Group 3 (n = 7) received the drug twice: from day 3 to day 8 and from day 25 to day 29. Group 4 (control, n = 5) only received water without the drug. The animals were withdrawn from the experiment on days 16, 30, and 90. Adenomyosis was confirmed by morphological examination. RESULTS: Tamoxifen should be administered once to create an adequate rat model of adenomyosis, from day 2 to day 5 of postembryonic development, and the animals should be withdrawn from the experiment on day 30 of life, when the severity of the disease is sufficient and is confirmed by morphological examination. Such the scheme is reproducible and economically advantageous. CONCLUSIONS: The creation of the described model of adenomyosis is important for conducting further studies on the treatment of the disease using various schemes, methods, and dosages in alternative methods of therapy to be described in the second part of the experiment.

My notes (saved in your browser only)

Condition tags

adenomyosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (11)

Cited by (1)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0 · commercial use OK